SVP and Chief Scientific Officer Lars B. Abrahmsen sold $124K of Aprea Therapeutics, Inc.

Sold$124,250

$4.97Price

25,000Shares

−57%Stake

What APRE did after the filing

Prices for APRE after this filing aren't in yet.

Traded Mon, Sep 20. Filed Wed, Sep 22, 1:00 PM ET, during the session. Not investment advice.